SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jonathan Schonsheck who wrote (4083)1/15/1999 10:30:00 AM
From: Jonathan Schonsheck  Read Replies (2) of 4342
 
Environmental Screening: and more $$$$$$

.
(3) Environmental Screening. The Company's patented Ah-IMMUNOASSAY(TM)
detects potentially toxic dioxins in the environment and provides quick,
accurate and inexpensive results compared to traditional analytical techniques.
The potential applications for this assay include commercial incinerators, the
organic farming industry and the general field of environmental management.
The Company has decided to focus its marketing and distribution resources on the
use of the Ah-IMMUNOASSAY(TM) to detect dioxins in the Japanese market for the
following reasons: (1) Japan has a serious dioxin pollution problem for which
the government has only recently begun to enforce emission requirements; (2)
incinerators that do not meet government emission requirements are being shut
down, causing disruption in many industries; (3) unlike the US and Western
European governments, the Japanese government has not imposed standards and
types of tests to be used in monitoring pollution discharge and as a result
companies are more open to new technologies which save money; and (4) unlike
their counterparts in the US and Western Europe, industry leaders have
acknowledged that dioxin is a problem. The Company is in final negotiations with
a large Japanese industrial conglomerate to license the Ah-IMMUNOASSAY(TM)
technology for screening dioxin pollution in Japan. The Company anticipates
receiving significant revenues from the agreement over the next three years.
Future revenues are anticipated to be derived from sales of the Company's
products and services that are currently under development and royalties in
connection with licensing of its technology.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News